A Holistic Overview on Current Development of Fluid-Based CNS Biomarkers
Time: 1:15 pm
day: Conference Day One
Details:
- Evaluating the use of novel fluid-based biomarkers of neurodegeneration
- Outlining the most recent advancements in fluid biomarker development across neurodegenerative and neuroinflammatory conditions
- Assessing the importance of fluid-based biomarkers, such as amyloid beta, tau and alpha synuclein
